Discover
CAMP
CAMP4 THERAPEUTICS CORPORATION
4.34
2 x 3.22
2 x 5.47
bid
ask
-
0.03
0.69%
2 @ 04:00 PM
4.34 +0.00 (0.00%)
| Ytd | -29.20% | |
| 1y | 221.48% |
4.17
day range
4.53
1.32
52 week range
7.75
| Open | 4.37 | Prev Close | 4.37 | Low | 4.17 | High | 4.53 | Mkt Cap | 225.36M |
| Vol | 146.14K | Avg Vol | 157.49K | EPS | -2.35 | P/E | N/A | Forward P/E | -2.52 |
| Beta | 1.89 | Short Ratio | 2.72 | Inst. Own | 42.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 4.26 | 200-d Avg | 4.33 | 1yr Est | 19.91 |
| Income Statement | |||
| Total Revenue | 1.29M | ||
| Revenues (USD) | 1.29M | ||
| Gross Profit | 1.29M | ||
| Operating Expenses | 14.37M | ||
| Research and Development Expense | 10.16M | ||
| Selling, General and Administrative Expense | 4.21M | ||
| Operating Income | -13.07M | ||
| Net Income | -18.33M | ||
| Net Income Common Stock | -18.33M | ||
| Net Income Common Stock (USD) | -18.33M | ||
| Consolidated Income | -18.33M | ||
| Earnings per Basic Share | -0.32 | ||
| Earnings per Basic Share (USD) | -0.32 | ||
| Earnings per Diluted Share | -0.32 | ||
| Earning Before Interest & Taxes (EBIT) | -18.33M | ||
| Earning Before Interest & Taxes (USD) | -18.33M | ||
| Weighted Average Shares | 57.92M | ||
| Weighted Average Shares Diluted | 57.92M | ||
| Balance Sheet | |||
| Cash and Equivalents | 99.94M | ||
| Cash and Equivalents (USD) | 99.94M | ||
| Investments | 894.00K | ||
| Investments Non-Current | 894.00K | ||
| Current Assets | 102.20M | ||
| Property, Plant & Equipment Net | 2.29M | ||
| Total Assets | 105.46M | ||
| Debt Current | 384.00K | ||
| Total Debt | 2.12M | ||
| Current Liabilities | 16.62M | ||
| Debt Non-Current | 1.74M | ||
| Total Liabilities | 74.56M | ||
| Accumulated Retained Earnings (Deficit) | -310.49M | ||
| Shareholders Equity | 30.90M | ||
| Shareholders Equity (USD) | 30.90M | ||
| Assets Non-Current | 3.26M | ||
| Total Debt (USD) | 2.12M | ||
| Deferred Revenue | 16.29M | ||
| Liabilities Non-Current | 57.93M | ||
| Trade and Non-Trade Payables | 863.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 554.00K | ||
| Net Cash Flow from Financing | 57.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.92M | ||
| Issuance (Purchase) of Equity Shares | 57.00K | ||
| Net Cash Flow from Operations | -10.98M | ||
| Share Based Compensation | 1.47M | ||